DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Cyclofenil

Cyclofenil

  • Us Anti-Doping Agency

    Us Anti-Doping Agency

  • University of Groningen Multi-Residue Analysis of Growth Promotors In

    University of Groningen Multi-Residue Analysis of Growth Promotors In

  • United States Patent 19 11 Patent Number: 5,446,070 Mantelle (45) Date of Patent:

    United States Patent 19 11 Patent Number: 5,446,070 Mantelle (45) Date of Patent: "Aug

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • February 18, 1999

    February 18, 1999

  • Reversal of Acquired Resistance to Doxorubicin in P388 Murine Leukemia Cells by Tamoxifen and Other Triparanol Analogues1

    Reversal of Acquired Resistance to Doxorubicin in P388 Murine Leukemia Cells by Tamoxifen and Other Triparanol Analogues1

  • Pharmaceuticals and Medical Devices Safety Information No

    Pharmaceuticals and Medical Devices Safety Information No

  • R. SCHWANTJE and H.-D

    R. SCHWANTJE and H.-D

  • 2019 Prohibited List

    2019 Prohibited List

  • United States Patent (19) 11 4,244,949 Gupta 45) Jan

    United States Patent (19) 11 4,244,949 Gupta 45) Jan

  • Anti-Doping Convention

    Anti-Doping Convention

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • The Medical Treatment of Endometriosis with Danazol

    The Medical Treatment of Endometriosis with Danazol

  • Pharmacy and Poisons Act 1979

    Pharmacy and Poisons Act 1979

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • Improvement in Aqueous Solubility of Achiral Symmetric Cyclofenil by Modification to a Chiral Asymmetric Analog

    Improvement in Aqueous Solubility of Achiral Symmetric Cyclofenil by Modification to a Chiral Asymmetric Analog

  • Drug-Induced Immune Hemolytic Anemia—The Last Decade

    Drug-Induced Immune Hemolytic Anemia—The Last Decade

  • Banned Substances

    Banned Substances

Top View
  • (12) United States Patent (10) Patent No.: US 8,668,925 B2 Langguth Et Al
  • Examples of Prohibited and Permitted Substances And
  • LPGA Prohibited Substances List
  • Customs Tariff - Schedule Xxi - 1
  • Oral Bromocriptine-Containing Products Authorised for Inhibition of Lactation
  • Estrogen Receptor/ERR
  • Examples of Prohibited Substances & Methods
  • Biological Activity and Steroid Receptor Interactions of Pituitary Gland And
  • Tepzz¥5Z 54¥A T
  • (12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
  • Evaluating Estrogen Receptor Signaling in Pancreatic Β-Cells
  • NFL List of Prohibited Substances I. ANABOLIC AGENTS
  • WADA 2018 Prohibited List
  • Mesh Terms for 2002
  • ATC Vet 2021 Atccode Atcdescription Atcdescriptionsi QA ALIMENTARY TRACT and METABOLISM ZDRAVILA ZA BOLEZNI PREBAVIL in PRESNOVE
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • Position Stand on Androgen and Human Growth Hormone Use
  • Massachusetts Gaming Commission 205 Cmr 3.00


© 2024 Docslib.org    Feedback